Market News
Friday, August 19, 2016
BRIEF-FDA approves Pfizer's TROXYCA ER extended-release capsules CII for pain management
* FDA approves TROXYCA ER (oxycodone hydrochloride and
naltrexone hydrochloride) extended-release CAPSULES CII with
abuse-deterrent properties for the management of pain
Source text for Eikon:...
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment